27 related articles for article (PubMed ID: 6779945)
1. Lipoatrophy in a patient on highly purified beef insulin.
Evans-Jones LG
Arch Dis Child; 1982 Aug; 57(8):638-9. PubMed ID: 7051987
[No Abstract] [Full Text] [Related]
2. The new insulins. Their characteristics and clinical indications.
Home PD; Alberti KG
Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical lipodystrophic changes due to conventional bovine and highly purified porcine/bovine insulins.
Campbell IW; Duncan C; Anani AR
Postgrad Med J; 1984 Jun; 60(704):439-41. PubMed ID: 6379631
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
Wilson RM; Douglas CA; Tattersall RB; Reeves WG
Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477
[TBL] [Abstract][Full Text] [Related]
5. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
[TBL] [Abstract][Full Text] [Related]
6. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
Czyzyk A; Rogala H; Lawecki J
Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
[TBL] [Abstract][Full Text] [Related]
7. The skin in diabetes mellitus.
Goodfield MJ; Millard LG
Diabetologia; 1988 Aug; 31(8):567-75. PubMed ID: 2578030
[No Abstract] [Full Text] [Related]
8. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
Richardson T; Kerr D
Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
[TBL] [Abstract][Full Text] [Related]
9. Lipoatrophy and monocomponent porcine insulin.
Jones GR; Statham B; Owens DR; Jones MK; Hayes TM
Br Med J (Clin Res Ed); 1981 Jan; 282(6259):190. PubMed ID: 6779945
[No Abstract] [Full Text] [Related]
10. A case of lipoatrophy with human insulin-therapy.
Chantelau E; Reuter M; Schotes S; Starke AA
Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
[TBL] [Abstract][Full Text] [Related]
11. A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication.
Ampudia-Blasco FJ; Girbes J; Carmena R
Diabetes Care; 2005 Dec; 28(12):2983. PubMed ID: 16306570
[No Abstract] [Full Text] [Related]
12. [Comparison of the effects of chromatographically purified insulin TZF-Polfa and highly purified insulin Nordisk on insulin-induced lipoatrophy].
Leowski J; TatoĊ J; Czech A; Laz R
Pol Tyg Lek; 1987 Dec; 42(50):1577-80. PubMed ID: 3330794
[No Abstract] [Full Text] [Related]
13. [Single-peak and monocomponent insulins].
Dorner M; Kuntzmann F; Pinget M
Rev Prat; 1978 Sep; 28(41):3095-8, 3101-2. PubMed ID: 715348
[No Abstract] [Full Text] [Related]
14. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
Holstein A; Stege H; Kovacs P
Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
